Introduction

The MedInProt Protein Science Research Synergy Program (MedInProt) is a unique niche initiative in Hungary which aims to:

  • link different protein science disciplines
  • organize and strengthen their network
  • achieve competitive collaboration
  • catalyze synergy among specialities
  • support recognized researchers' co-operation

The objective of the program, which is financed by the Hungarian Academy of Sciences, is to foster cooperation among a number of universities: the Eötvös Loránd University, the Budapest University of Technology and Economy, the Semmelweis University and the Hungarian Academy of Sciences Research Center for Natural Sciences. 20th May 2014 marked the inaugural conference of the MedInProt Program, whose president is Dr András Perczel.

The first phase of the program (2014 - 2015) was concerned with research into the fields of protein science. We will support some researcher to buy small and medium-sized equipment, and will finance them a measure of computer time.

MedInProt's remit includes the organisation and support of conferences and courses and the establishment of an MSc program in English. In addition, the program will be involved in setting up a troubleshooting hotline, and the purchase and translation of books relating to the field of protein science.


Events

Upcoming

More Upcoming Events

Recent

More Recent Events

News

Molecular Frontiers Symposium 2017-06-07

September 14-15. 2017, at Eötvös Loránd University

Molecular Frontiers (www.molecularfrontiers.org) is an international network formed by researchers and professors. This organization focuses on highlighting the importance of molecular sciences in a wide range of society, thus attracting young people towards science. Molecular Frontiers Symposia, organized for the upper purpose gathers leading scientists of the Globe, usually to discuss the topic of a current global problem. The actual issue and the attendees of these events are decided by the Scientific Committee (many members of which are Nobel laureate scientists); thus young student (age usually from 14 to 25) and other participants have the opportunity to meet the top researchers of the field. Further information regarding past events at: http://www.molecularfrontiers.org/symposia).

On each symposia 10 to 12 researcher hold lectures many of whom have received a Nobel Prize. On the demonstrating photo a group picture of the 2015 event in Göteborg can be seen. More than 1000 students and researchers attend Molecular Frontiers events, moreover, thanks to the recently initiated live broadcasting via internet, Molecular Frontiers Symposia are becoming rapidly expanding international events.

We believe that the Hungarian organization of such a prestigious event not only furthers molecular science’s popularity and recognition among the young, but also promotes the international (mostly inter EU) recognition of Hungarian research, thus, fulfilling an important national interest. The currently chosen topic shall follow the theme of an actual Hungarian program known as MedInProt initiative, with the purpose of assisting the communication among scientists working in the fields of protein sciences and pharmacology. The goal of MedInProt and Molecular Frontiers is to efficiently support the more successful integration of Hungarian scientists into the international network.

Program

https://www.mke.org.hu/MolecularFrontiers2017/en/


Tavaszi lendület a MedInProtnál 2017-05-02

Friss ötletek - gyors támogatás: jelentkezzen még ma!
(Az Ön ötlete és kezdeményezése nekünk is fontos! )

Vesse föl új és eredeti ötletét, akár még ma, nyújtsa be támogatási igényét, és a MedInProt kuratóriuma rövid megfontolás után, ha a kezdeményezést méltónak találja, azonnal támogatja is. „first come first served”.

Figyelmébe ajánlom „Megvalósíthatósági” programunkat (http://medinprot.chem.elte.hu/hu/palyazatok/uj-palyazatok)

Támogathatósági feltételek:
- a szinergiában résztvevő kutatók közül legalább az egyik a 4 központi intézmény (ELTE, BME, MTA-TTK, SE) valamelyikében legyen főállású közalkalmazott,
- a javaslat világosan mutasson rá arra, hogy Ön és társa(i) az ad hoc támogatásnak köszönhetően hogyan jutnak közelebb hosszú távú a közös munkához és egy közös pályázáshoz akár hazai, akár nemzetközi fórumon.

Jelen „ad hoc” támogatás volumene:
200 eFt <= x <= 2M Ft (eltérés csak kiemelten indokolt esetben lehetséges)

Jelen „ad hoc” támogatás pályázási határideje:
2017. május 10.
Beadás módja:
Küldje el a medinprot@chem.elte.hu e-mail címre.

Budapest, 2017. május 2.

Perczel András
a MEDinPROT kuratórium elnöke


6. Conference of MedInProt - presented at the conference 2017-04-25

The sixth Conference of the MedInProt Protein Science Research Synergy Program was held on April 22. 2017, at Eötvös Loránd University.

Gábor Mező: Development of bioconjugates and their modules for targeted treatment of cancers with high mortality rate

Beáta Vértessy: K-RAS oncogen mutations: structure-based allele specific inhibitor design

Balázs Győrffy: Investigating pediatric solid tumors with worst prognosis

Studying in vivo effect of cell-penetrating inhibitor peptide conjugate on protein-protein interaction

Development of a high-throughput, label-free optical system to evaluate the interaction of enzymes involved in inflammation with cells

High-sensitivity mass spectrometry analysis of pericardial fluid derived extracellular vesicles (EVs)

Examination of poly (N-isopropylacrylamide) and globular and disordered proteins temperature dependent interactions by NMR spectroscopy

Subcellular compartmentation of ascorbate and epigenetics

Monitoring of biodistribution of peptide-based drug delivery system by MRI

Improving LC-MS/MS characteristics of peptides with fluorine modifications for proteomic use

Sum-frequency spectroscopy

Studying the interaction of antituberculotic substances and antimicrobial carrier peptides with human serum a1 acidic glycoprotein


6. Conference of MedInProt - visiting lecturers 2017-04-10

Visiting lecturers

Gábor Mező: Development of bioconjugates and their modules for targeted treatment of cancers with high mortality rate

There is increased interest in peptide based targeting moieties for drug delivery in targeted tumor therapy, that recognize the specific or overexpressed receptors on tumor cells with high selectivity. Despite there are promising results with peptide – drug conjugates, their application in combination similarly to chemotherapy might have benefits. For this purpose we would like to develop molecular libraries which modules (drugs, homing peptides and bifunctional linkers) can be attach to each other in high combination to develop numerous conjugates suitable for targeted tumor therapy.

Beáta Vértessy: K-RAS oncogen mutations: structure-based allele specific inhibitor design

Balázs Győrffy: Investigating pediatric solid tumors with worst prognosis

Malignant diseases represent the leading cause of death for those below 14 years of age. While treatment of hemato-oncologic malignancies can almost completely heal a patient, half of patients with a solid tumor are lost within ten years. In our project we will gain new insights into the development of solid tumors by linking molecular and epidemiologic data.


6. Conference of MedInProt 2017-04-10

We cordially invite you to the 6th MedInProt Conference held at ELTE TTK Eötvös lecture hall on Saturday, April 22, 2017 starting at 9 AM.
Winners of the Synergy V Program and the Grant Facilitating Access to Instruments Program shall present their joint research at the conference. In addition, NVKP winners Gábor Mező (ELTE), Beáta Vértessy (BME) and Balázs Győrffy (MTA) will give lectures.
The conference will end with sweepstakes and poster discussions.
All interested are invited and welcome!

Program

More News